These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36588502)

  • 1. Apathy in patients with Alzheimer's disease is a cost-driving factor.
    Kruse C; Maier F; Spottke A; Bach JP; Bartels C; Buerger K; Fellgiebel A; Fliessbach K; Frölich L; Hausner L; Hellmich M; Klöppel S; Klostermann A; Kornhuber J; Laske C; Peters O; Priller J; Richter-Schmidinger T; Schneider A; Shah-Hosseini K; Teipel S; von Arnim CAF; Wiltfang J; van der Wurp H; Dodel R; Jessen F
    Alzheimers Dement; 2023 Jul; 19(7):2853-2864. PubMed ID: 36588502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2).
    Lanctôt KL; Chen C; Mah E; Kiss A; Li A; Shade D; Scherer RW; Vieira D; Coulibaly H; Rosenberg PB; Lerner AJ; Padala PR; Brawman-Mintzer O; van Dyck CH; Porsteinsson AP; Craft S; Levey A; Burke WJ; Mintzer J; Herrmann N
    Int Psychogeriatr; 2023 Nov; 35(11):664-672. PubMed ID: 37066690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial.
    Forstmeier S; Maercker A; Savaskan E; Roth T
    Trials; 2015 Nov; 16():526. PubMed ID: 26576633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study.
    Robert PH; Berr C; Volteau M; Bertogliati C; Benoit M; Sarazin M; Legrain S; Dubois B;
    Clin Neurol Neurosurg; 2006 Dec; 108(8):733-6. PubMed ID: 16567037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale.
    Matsui T; Nakaaki S; Murata Y; Sato J; Shinagawa Y; Tatsumi H; Furukawa TA
    Dement Geriatr Cogn Disord; 2006; 21(3):182-91. PubMed ID: 16401890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated with Apathy in Alzheimer's Disease: A Cross-Sectional Analysis of the Texas Alzheimer's Research and Care Consortium (TARCC) Study.
    Teixeira AL; Salem H; Martins LB; Gonzales MM; Seshadri S; Suchting R
    J Alzheimers Dis; 2022; 86(1):403-411. PubMed ID: 35068461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial.
    Maier F; Spottke A; Bach JP; Bartels C; Buerger K; Dodel R; Fellgiebel A; Fliessbach K; Frölich L; Hausner L; Hellmich M; Klöppel S; Klostermann A; Kornhuber J; Laske C; Peters O; Priller J; Richter-Schmidinger T; Schneider A; Shah-Hosseini K; Teipel S; von Arnim CAF; Wiltfang J; Jessen F
    JAMA Netw Open; 2020 May; 3(5):e206027. PubMed ID: 32463470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study.
    Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW
    BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of neuropsychiatric symptoms of Alzheimer's disease on Chinese and American caregivers.
    Pang FC; Chow TW; Cummings JL; Leung VP; Chiu HF; Lam LC; Chen QL; Tai CT; Chen LW; Wang SJ; Fuh JL
    Int J Geriatr Psychiatry; 2002 Jan; 17(1):29-34. PubMed ID: 11802227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.
    Lanctôt KL; Scherer RW; Li A; Vieira D; Coulibaly H; Rosenberg PB; Herrmann N; Lerner AJ; Padala PR; Brawman-Mintzer O; van Dyck CH; Porsteinsson AP; Craft S; Levey A; Burke WJ; Mintzer JE
    Am J Geriatr Psychiatry; 2021 Jan; 29(1):81-89. PubMed ID: 32565008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Padala PR; Padala KP; Lensing SY; Ramirez D; Monga V; Bopp MM; Roberson PK; Dennis RA; Petty F; Sullivan DH; Burke WJ
    Am J Psychiatry; 2018 Feb; 175(2):159-168. PubMed ID: 28945120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and Resource Use Associated with Alzheimer's Disease in Italy: Results from an Observational Study.
    Bruno G; Mancini M; Bruti G; Dell'Agnello G; Reed C
    J Prev Alzheimers Dis; 2018; 5(1):55-64. PubMed ID: 29405234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anosognosia and neuropsychiatric symptoms on the quality of life of patients with Alzheimer's disease: a 24-month follow-up study.
    Conde-Sala JL; Turró-Garriga O; Piñán-Hernández S; Portellano-Ortiz C; Viñas-Diez V; Gascón-Bayarri J; Reñé-Ramírez R
    Int J Geriatr Psychiatry; 2016 Feb; 31(2):109-19. PubMed ID: 25963296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular dementia versus dementia of Alzheimer's type: do they have differential effects on caregivers' burden?
    Vetter PH; Krauss S; Steiner O; Kropp P; Möller WD; Moises HW; Köller O
    J Gerontol B Psychol Sci Soc Sci; 1999 Mar; 54(2):S93-8. PubMed ID: 10097779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric symptoms and activities of daily living in Alzheimer's disease: ALSOVA 5-year follow-up study.
    Saari T; Hallikainen I; Hintsa T; Koivisto AM
    Int Psychogeriatr; 2020 Jun; 32(6):741-751. PubMed ID: 31656211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caregiver rating bias in mild cognitive impairment and mild Alzheimer's disease: impact of caregiver burden and depression on dyadic rating discrepancy across domains.
    Pfeifer L; Drobetz R; Fankhauser S; Mortby ME; Maercker A; Forstmeier S
    Int Psychogeriatr; 2013 Aug; 25(8):1345-55. PubMed ID: 23651733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer's disease.
    Frakey LL; Salloway S; Buelow M; Malloy P
    J Clin Psychiatry; 2012 Jun; 73(6):796-801. PubMed ID: 22687392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apathy and Disinhibition Related to Neuropathology in Amnestic Versus Behavioral Dementias.
    Borges LG; Rademaker AW; Bigio EH; Mesulam MM; Weintraub S
    Am J Alzheimers Dis Other Demen; 2019 Aug; 34(5):337-343. PubMed ID: 31170813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a non-focal plasticity protocol on apathy in moderate Alzheimer's disease: a randomized, double-blind, sham-controlled trial.
    Suemoto CK; Apolinario D; Nakamura-Palacios EM; Lopes L; Leite RE; Sales MC; Nitrini R; Brucki SM; Morillo LS; Magaldi RM; Fregni F
    Brain Stimul; 2014; 7(2):308-13. PubMed ID: 24262299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment.
    Grisanti SG; Massa F; Chincarini A; Pretta S; Rissotto R; Serrati C; Monacelli F; Serafini G; Calcagno P; Brugnolo A; Pardini M; Nobili F; Girtler N;
    J Alzheimers Dis; 2023; 93(1):75-86. PubMed ID: 36938731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.